Literature DB >> 20427668

Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males.

Georgina M Russell1, David E Henley, Jack Leendertz, Jennie A Douthwaite, Susan A Wood, Adam Stevens, Wolfram W Woltersdorf, Bernard W M M Peeters, Ge S F Ruigt, Anne White, Johannes D Veldhuis, Stafford L Lightman.   

Abstract

A complex dynamic ultradian rhythm underlies the hypothalamic-pituitary-adrenal (HPA) circadian rhythm. We have investigated in normal human male subjects the importance, site of action, and receptor-mediated processes involved in rapid basal corticosteroid feedback and its interaction with corticotrophin releasing hormone (CRH) drive. Pro-opiomelanocortin (POMC), ACTH, and cortisol were measured every 10 min from healthy males during the awakening period or late afternoon using an automated blood sampling system. Mathematical modeling into discrete pulses of activity revealed that intravenous infusion of the synthetic mixed glucocorticoid/mineralocorticoid agonist prednisolone produced rapid inhibition of ACTH and cortisol pulsatility within 30 min in the morning and afternoon. Any pulse that had commenced at the time of injection was unaffected, and subsequent pulsatility was inhibited. Prednisolone also inhibited ACTH and cortisol secretion in response to exogenous CRH stimulation, inferring rapid feedback inhibition at the anterior pituitary. Circulating POMC peptide concentrations were unaffected, suggesting that the rapid corticosteroid inhibitory effect specifically targeted ACTH secretion from pituitary corticotrophs. Prednisolone fast feedback was only reduced by glucocorticoid receptor antagonist pretreatment and not by mineralocorticoid receptor antagonism, suggesting a glucocorticoid receptor-mediated pathway. The intravenous prednisolone suppression test provides a powerful new tool to investigate HPA abnormalities underlying metabolic and psychiatric disease states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427668      PMCID: PMC6632590          DOI: 10.1523/JNEUROSCI.5332-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Transcriptional implications of ultradian glucocorticoid secretion in homeostasis and in the acute stress response.

Authors:  Jeremy D Scheff; Steve E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  Physiol Genomics       Date:  2011-11-29       Impact factor: 3.107

Review 2.  Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.

Authors:  Anthony S Zannas; Tobias Wiechmann; Nils C Gassen; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2015-08-13       Impact factor: 7.853

3.  Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.

Authors:  Ileana A Ionita; Ken Ogasawara; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Ther Drug Monit       Date:  2014-08       Impact factor: 3.681

Review 4.  A users guide to HPA axis research.

Authors:  Robert L Spencer; Terrence Deak
Journal:  Physiol Behav       Date:  2016-11-18

5.  Ontogeny of hypothalamic glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in mice.

Authors:  Gloria Laryea; Melinda Arnett; Louis J Muglia
Journal:  Stress       Date:  2015-06-11       Impact factor: 3.493

Review 6.  Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis.

Authors:  M N Hill; J G Tasker
Journal:  Neuroscience       Date:  2011-12-24       Impact factor: 3.590

Review 7.  Epigenetics and the regulation of stress vulnerability and resilience.

Authors:  A S Zannas; A E West
Journal:  Neuroscience       Date:  2013-12-13       Impact factor: 3.590

8.  Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis.

Authors:  Jeffrey G Tasker; James P Herman
Journal:  Stress       Date:  2011-07       Impact factor: 3.493

Review 9.  Hormonal Treatments for Major Depressive Disorder: State of the Art.

Authors:  Jennifer B Dwyer; Awais Aftab; Rajiv Radhakrishnan; Alik Widge; Carolyn I Rodriguez; Linda L Carpenter; Charles B Nemeroff; William M McDonald; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2020-05-27       Impact factor: 18.112

10.  Tonic, but not phasic corticosterone, constrains stress activatedextracellular-regulated-kinase 1/ 2 immunoreactivity within the hypothalamic paraventricular nucleus.

Authors:  C D Osterlund; E Jarvis; A Chadayammuri; R Unnithan; M J Weiser; R L Spencer
Journal:  J Neuroendocrinol       Date:  2011-12       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.